Immediate Impact
67 standout
Citing Papers
Glomerulonephritis: immunopathogenesis and immunotherapy
2023 Standout
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
2023 Standout
Works of V. Anantharaman being referenced
The changing pattern of primary glomerulonephritis in Singapore and other countries over the past 3 decades
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| V. Anantharaman | 335 | 80 | 71 | 198 | 165 | 48 | 767 | |
| Jaehoon Oh | 438 | 60 | 50 | 94 | 206 | 95 | 851 | |
| Lior Fuchs | 112 | 109 | 37 | 164 | 96 | 53 | 743 | |
| Diana Handrahan | 227 | 76 | 34 | 61 | 222 | 28 | 751 | |
| Mohammed Alshahrani | 127 | 56 | 34 | 39 | 263 | 51 | 763 | |
| S. Cohen | 67 | 70 | 72 | 180 | 65 | 44 | 816 | |
| Shiying Hao | 100 | 55 | 19 | 127 | 98 | 35 | 705 | |
| Weidun Alan Guo | 143 | 190 | 33 | 47 | 119 | 44 | 850 | |
| Justin Boyle | 348 | 56 | 105 | 84 | 28 | 70 | 807 | |
| Kathryn G. Kuttler | 181 | 51 | 32 | 147 | 93 | 29 | 801 | |
| Jörg Haasenritter | 94 | 127 | 30 | 338 | 128 | 50 | 939 |
All Works
Loading papers...